We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+3.27%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$477M
AUM Growth
-$8.91M
Cap. Flow
-$21.5M
Cap. Flow %
-4.51%
Top 10 Hldgs %
33.08%
Holding
125
New
9
Increased
29
Reduced
73
Closed
5

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$3.71M
2
BAX icon
Baxter International
BAX
+$3.16M
3
CAMP
CalAmp Corp.
CAMP
+$2.58M
4
CGW icon
Invesco S&P Global Water Index ETF
CGW
+$1.69M
5
ATHM icon
Autohome
ATHM
+$1.67M

Top Sells

Rank Stock Value
1
OTTR icon
Otter Tail
OTTR
+$5.75M
2
ADM icon
Archer Daniels Midland
ADM
+$3.95M
3
BCE icon
BCE
BCE
+$2.77M
4
GVA icon
Granite Construction
GVA
+$2.59M
5
DUK icon
Duke Energy
DUK
+$2.47M

Sector Composition

Rank Sector Weight
1 Healthcare 26.1%
2 Industrials 18.87%
3 Technology 17.72%
4 Energy 8.76%
5 Utilities 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STJ
26
DELISTED
St Jude Medical
STJ
$5.9M 1.24%
73,568
– –
BCE icon
27
BCE
BCE
$19.8B
$5.85M 1.22%
135,227
-62,809
-32% -$2.77M
EXC icon
28
Exelon
EXC
$48.2B
$5.82M 1.22%
229,970
-5,748
-2% -$136K
GXP
29
DELISTED
Great Plains Energy Incorporated
GXP
$5.59M 1.17%
204,410
+21,125
+12% +$577K
MDU icon
30
MDU Resources
MDU
$4.37B
$5.48M 1.15%
500,927
-50,494
-9% -$522K
LFCR icon
31
Lifecore Biomedical
LFCR
$163M
$5.28M 1.11%
382,475
-24,950
-6% -$346K
NEE icon
32
NextEra Energy
NEE
$185B
$5.25M 1.1%
175,740
-3,300
-2% -$98.6K
CHMG icon
33
Chemung Financial Corp
CHMG
$388M
$5.15M 1.08%
141,563
-969
-0.7% -$30.6K
WTS icon
34
Watts Water Technologies
WTS
$11.5B
$5.08M 1.06%
77,925
-700
-0.9% -$45.8K
AMAT icon
35
Applied Materials
AMAT
$410B
$5.05M 1.06%
156,477
-373
-0.2% -$11.3K
IDA icon
36
Idacorp
IDA
$8.2B
$4.93M 1.03%
61,260
-1,850
-3% -$143K
CGW icon
37
Invesco S&P Global Water Index ETF
CGW
$1.05B
$4.82M 1.01%
169,550
+58,100
+52% +$1.69M
DGX icon
38
Quest Diagnostics
DGX
$25.6B
$4.71M 0.99%
51,249
+2,263
+5% +$195K
GSK icon
39
GSK
GSK
$104B
$4.68M 0.98%
97,318
-40,748
-30% -$2.01M
BAX icon
40
Baxter International
BAX
$12.1B
$4.6M 0.96%
103,646
+68,427
+194% +$3.16M
MON
41
DELISTED
Monsanto Co
MON
$4.51M 0.94%
42,840
-1,050
-2% -$108K
MENT
42
DELISTED
Mentor Graphics Corp
MENT
$4.5M 0.94%
121,867
-1,500
-1% -$49K
AGCO icon
43
AGCO
AGCO
$8.71B
$4.47M 0.94%
77,200
-400
-0.5% -$21.6K
LGTY
44
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$4.33M 0.91%
418,885
+8,600
+2% +$91.9K
CIEN icon
45
Ciena
CIEN
$53.4B
$3.92M 0.82%
160,400
-16,700
-9% -$365K
TMO icon
46
Thermo Fisher Scientific
TMO
$208B
$3.8M 0.8%
26,933
-484
-2% -$71.4K
HLIO icon
47
Helios Technologies
HLIO
$2.59B
$3.77M 0.79%
94,425
-25,400
-21% -$910K
HAL icon
48
Halliburton
HAL
$26.8B
$3.74M 0.78%
69,184
-1,700
-2% -$84.8K
CCC
49
DELISTED
Calgon Carbon Corp
CCC
$3.73M 0.78%
219,700
-2,250
-1% -$37.6K
XBI icon
50
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$3.43M 0.72%
57,920
+1,200
+2% +$74.1K
1
2
3 4 5

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
SF
Symphony Financial Houston, Texas $755M AUM 25.99% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return

John G. Ullman & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, John G. Ullman & Associates held 125 positions worth $477M, down 1.8% from $486M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates withdrew a net $21.5M in Q4 2016, closing 5 positions and reducing 73 holdings. Its most notable exit was Scana, an estimated $2.43M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Technology.

Against the trend, John G. Ullman & Associates opened a new position in CalAmp Corp. worth $2.62M.

  • John G. Ullman & Associates's largest Q4 2016 buy was CalAmp Corp.: 7,852 shares worth $2.62M.
  • John G. Ullman & Associates added most to Novartis in Q4 2016, an estimated $3.71M increase.
  • John G. Ullman & Associates's biggest Q4 2016 reduction was Otter Tail, cutting an estimated $5.75M.
  • John G. Ullman & Associates fully exited Scana in Q4 2016, selling an estimated $2.43M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $477M portfolio in Q4 2016.
  • John G. Ullman & Associates opened 9 new positions and closed 5 in Q4 2016.
  • John G. Ullman & Associates's portfolio value fell 1.8% quarter-over-quarter to $477M.

Based on John G. Ullman & Associates's 13F filing for Q4 2016, filed 20 Jan 2017.